BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2449079)

  • 1. Predictive value of preoperative serum CA 125 levels in clinically localized and advanced endometrial carcinoma.
    Patsner B; Mann WJ; Cohen H; Loesch M
    Am J Obstet Gynecol; 1988 Feb; 158(2):399-402. PubMed ID: 2449079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenocarcinoma of the uterine cervix. Prognostic significance of pretreatment serum CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen levels in relation to clinical and histopathologic tumor characteristics.
    Duk JM; De Bruijn HW; Groenier KH; Fleuren GJ; Aalders JG
    Cancer; 1990 Apr; 65(8):1830-7. PubMed ID: 2317761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CA 125: a useful marker in endometrial carcinoma.
    Duk JM; Aalders JG; Fleuren GJ; de Bruijn HW
    Am J Obstet Gynecol; 1986 Nov; 155(5):1097-102. PubMed ID: 3465243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of serum CA-125 in monitoring patients with uterine sarcoma. A preliminary report.
    Patsner B; Mann WJ
    Cancer; 1988 Oct; 62(7):1355-8. PubMed ID: 3166396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CA 125, NB/70K, and lipid-associated sialic acid in monitoring uterine papillary serous carcinoma.
    Tseng PC; Sprance HE; Carcangiu ML; Chambers JT; Schwartz PE
    Obstet Gynecol; 1989 Sep; 74(3 Pt 1):384-7. PubMed ID: 2761916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CA 125 in gynecologic practice.
    Malkasian GD; Podratz KC; Stanhope CR; Ritts RE; Zurawski VR
    Am J Obstet Gynecol; 1986 Sep; 155(3):515-8. PubMed ID: 2428248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preoperative levels of CA 125 and risk factors in adenocarcinoma of the endometrium].
    Marcello C; Corda F; Pilloni MD; Puligheddu P; Lecca U
    Ann Ostet Ginecol Med Perinat; 1989; 110(6):290-5. PubMed ID: 2639616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of serum CA-125 in predicting extra-uterine disease in apparent early-stage endometrial cancer.
    Nicklin J; Janda M; Gebski V; Jobling T; Land R; Manolitsas T; McCartney A; Nascimento M; Perrin L; Baker JF; Obermair A;
    Int J Cancer; 2012 Aug; 131(4):885-90. PubMed ID: 21918977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentrations of CA-125 tumor marker in endometrial carcinoma.
    Kukura V; Zaninović I; Hrdina B
    Gynecol Oncol; 1990 Jun; 37(3):388-9. PubMed ID: 2351323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical expression of CA 125 in endometrial adenocarcinoma: correlation of antigen expression with metastatic potential.
    Berchuck A; Soisson AP; Clarke-Pearson DL; Soper JT; Boyer CM; Kinney RB; McCarty KS; Bast RC
    Cancer Res; 1989 Apr; 49(8):2091-5. PubMed ID: 2702650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative serum CA-125 levels in treating endometrial cancer.
    Powell JL; Hill KA; Shiro BC; Diehl SJ; Gajewski WH
    J Reprod Med; 2005 Aug; 50(8):585-90. PubMed ID: 16220763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative evaluation of serum CA 125, TAG 72, and CA 15-3 in patients with endometrial carcinoma.
    Soper JT; Berchuck A; Olt GJ; Soisson AP; Clarke-Pearson DL; Bast RC
    Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 1):1204-9. PubMed ID: 2220931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CA-125 antigen in patients with cancer of the uterine body].
    Gisterek M; Wawrzkiewicz M; Kornafel J
    Wiad Lek; 1990 Sep 1-15; 43(17-18):866-9. PubMed ID: 2278143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated serum concentrations of CA-125 in patients with advanced endometriosis.
    Barbieri RL; Niloff JM; Bast RC; Scaetzl E; Kistner RW; Knapp RC
    Fertil Steril; 1986 May; 45(5):630-4. PubMed ID: 3457709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple serum markers in patients with endometrial cancer.
    Panici PB; Scambia G; Baiocchi G; Perrone L; Greggi S; Battaglia F; Mancuso S
    Gynecol Obstet Invest; 1989; 27(4):208-12. PubMed ID: 2744625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between clinical and surgical staging for endometrial cancer in Thailand.
    Buranawattanachoke S; Leelahakorn S; Tangjitgamol S; Manusirivithaya S; Khunnarong J
    Asian Pac J Cancer Prev; 2009; 10(4):685-90. PubMed ID: 19827895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative CA 125 in endometrial cancer: is it useful?
    Dotters DJ
    Am J Obstet Gynecol; 2000 Jun; 182(6):1328-34. PubMed ID: 10871446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative serum CA-125 levels in patients with surgical stage I invasive ovarian adenocarcinoma.
    Mann WJ; Patsner B; Cohen H; Loesch M
    J Natl Cancer Inst; 1988 Apr; 80(3):208-9. PubMed ID: 3162284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of exploratory laparotomy in patients with endometrial carcinoma according to the new International Federation of Gynecology and Obstetrics staging.
    Vardi JR; Tadros GH; Anselmo MT; Rafla SD
    Obstet Gynecol; 1992 Aug; 80(2):204-8. PubMed ID: 1635733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of Ca antigen in normal, hyperplastic and neoplastic endometrium.
    Ferguson AM; Fox H
    Br J Obstet Gynaecol; 1984 Oct; 91(10):1042-5. PubMed ID: 6386039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.